BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 38464517)

  • 1. A Rare Case of Early T-Precursor Lymphoblastic Lymphoma (ETP-LBL) in a Child With Nijmegen Breakage Syndrome.
    R Brannock K; Kahwash SB
    Pediatr Dev Pathol; 2024 May; ():10935266241255277. PubMed ID: 38794943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?
    Kroeze E; Loeffen JLC; Poort VM; Meijerink JPP
    Blood Adv; 2020 Jul; 4(14):3466-3473. PubMed ID: 32722786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
    Huang YH; Wan CL; Dai HP; Xue SL
    Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses.
    Ren Y; Liang H; Huang Y; Miao Y; Li R; Qiang J; Wu L; Qi J; Li Y; Xia Y; Huang L; Wang S; Kong X; Zhou Y; Zhang Q; Zhu G
    Front Immunol; 2024; 15():1341255. PubMed ID: 38464517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia.
    Liang H; Kong X; Cao Z; Wang H; Liu E; Sun F; Qi J; Zhang Q; Zhou Y
    Front Immunol; 2023; 14():1194353. PubMed ID: 37266435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma.
    Gao HX; Wang MB; Li SJ; Niu J; Xue J; Li J; Li XX
    Curr Med Sci; 2020 Oct; 40(5):885-899. PubMed ID: 32980897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Link between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients' Peripheral Blood Lymphocytes and Ferroptosis Susceptibility.
    Wang Y; Iha H
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.
    Agarwal S; Aznar MA; Rech AJ; Good CR; Kuramitsu S; Da T; Gohil M; Chen L; Hong SA; Ravikumar P; Rennels AK; Salas-Mckee J; Kong W; Ruella M; Davis MM; Plesa G; Fraietta JA; Porter DL; Young RM; June CH
    Immunity; 2023 Oct; 56(10):2388-2407.e9. PubMed ID: 37776850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIF11 serves as a cell cycle mediator in childhood acute lymphoblastic leukemia.
    Zhu L; Chen C; Kang M; Ma X; Sun X; Xue Y; Fang Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15609-15622. PubMed ID: 37656243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
    Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
    J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CDK1 in cancer: mechanisms and implications.
    Wang Q; Bode AM; Zhang T
    NPJ Precis Oncol; 2023 Jun; 7(1):58. PubMed ID: 37311884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases.
    Zhang Z; Li M; Sun T; Zhang Z; Liu C
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238726
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.